Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Integrative computational evaluation of genetic markers for Alzheimer's disease.

Li Z, Xiong Z, Manor LC, Cao H, Li T.

Saudi J Biol Sci. 2018 Jul;25(5):996-1002. doi: 10.1016/j.sjbs.2018.05.019. Epub 2018 May 18.

2.

Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease.

Baglietto-Vargas D, Prieto GA, Limon A, Forner S, Rodriguez-Ortiz CJ, Ikemura K, Ager RR, Medeiros R, Trujillo-Estrada L, Martini AC, Kitazawa M, Davila JC, Cotman CW, Gutierrez A, LaFerla FM.

Aging Cell. 2018 Jun 6:e12791. doi: 10.1111/acel.12791. [Epub ahead of print]

3.

Longitudinal Functional Brain Mapping in Supernormals.

Wang X, Ren P, Baran TM, Raizada RDS, Mapstone M, Lin F; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2017 Nov 23:1-11. doi: 10.1093/cercor/bhx322. [Epub ahead of print]

PMID:
29186360
4.

sRAGE prolonged stem cell survival and suppressed RAGE-related inflammatory cell and T lymphocyte accumulations in an Alzheimer's disease model.

Oh S, Son M, Choi J, Lee S, Byun K.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):807-813. doi: 10.1016/j.bbrc.2017.11.035. Epub 2017 Nov 7.

PMID:
29127006
5.
6.

Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.

Osgood D, Miller MC, Messier AA, Gonzalez L, Silverberg GD.

Neurobiol Aging. 2017 Sep;57:178-185. doi: 10.1016/j.neurobiolaging.2017.05.011. Epub 2017 May 19.

PMID:
28654861
7.

Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease.

Ferguson SA, Panos JJ, Sloper D, Varma V.

J Alzheimers Dis. 2017;59(1):57-66. doi: 10.3233/JAD-170204.

PMID:
28582866
8.

Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.

Saito S, Yamamoto Y, Maki T, Hattori Y, Ito H, Mizuno K, Harada-Shiba M, Kalaria RN, Fukushima M, Takahashi R, Ihara M.

Acta Neuropathol Commun. 2017 Apr 4;5(1):26. doi: 10.1186/s40478-017-0429-5.

9.

Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.

Wei M, Zhao B, Huo K, Deng Y, Shang S, Liu J, Li Y, Ma L, Jiang Y, Dang L, Chen C, Wei S, Zhang J, Yang H, Gao F, Qu Q.

J Alzheimers Dis. 2017;57(3):899-906. doi: 10.3233/JAD-161213.

PMID:
28304302
10.

Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice.

Zhao C, Zhang H, Li H, Lv C, Liu X, Li Z, Xin W, Wang Y, Zhang W.

Neuropharmacology. 2017 Apr;116:18-29. doi: 10.1016/j.neuropharm.2016.12.002. Epub 2016 Dec 6.

PMID:
27940040
11.

Multiple Targets for the Management of Alzheimer's Disease.

Ahmad SS, Akhtar S, Jamal QM, Rizvi SM, Kamal MA, Khan MK, Siddiqui MH.

CNS Neurol Disord Drug Targets. 2016;15(10):1279-1289. Review.

PMID:
27712576
12.

Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis.

Yu W, Yang J, Sui W, Qu B, Huang P, Chen Y.

Medicine (Baltimore). 2016 Sep;95(39):e4463. doi: 10.1097/MD.0000000000004463.

13.

Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.

Guo C, Zhang S, Li JY, Ding C, Yang ZH, Chai R, Wang X, Wang ZY.

Sci Rep. 2016 Jul 12;6:29396. doi: 10.1038/srep29396.

14.

DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.

Yamagishi S, Taguchi K, Fukami K.

Glycoconj J. 2016 Aug;33(4):683-90. doi: 10.1007/s10719-016-9682-2. Epub 2016 Jun 24.

PMID:
27338620
15.

[Fragment of Receptor for Advanced Glycation End Products Improves Memory State in a Model of Alzheimer's Disease].

Volpina OM, Koroev DO, Volkova TD, Kamynina AV, Filatova MP, Zaporozhskayva YV, Samokhin AN, Aleksandrova IJ, Bobkova NV.

Bioorg Khim. 2015 Nov-Dec;41(6):709-16. Russian.

PMID:
27125025
16.

Diabetes and Alzheimer's disease crosstalk.

Baglietto-Vargas D, Shi J, Yaeger DM, Ager R, LaFerla FM.

Neurosci Biobehav Rev. 2016 May;64:272-87. doi: 10.1016/j.neubiorev.2016.03.005. Epub 2016 Mar 9. Review.

PMID:
26969101
17.

Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction.

Manigrasso MB, Pan J, Rai V, Zhang J, Reverdatto S, Quadri N, DeVita RJ, Ramasamy R, Shekhtman A, Schmidt AM.

Sci Rep. 2016 Mar 3;6:22450. doi: 10.1038/srep22450.

18.

A Novel, Multi-Target Natural Drug Candidate, Matrine, Improves Cognitive Deficits in Alzheimer's Disease Transgenic Mice by Inhibiting Aβ Aggregation and Blocking the RAGE/Aβ Axis.

Cui L, Cai Y, Cheng W, Liu G, Zhao J, Cao H, Tao H, Wang Y, Yin M, Liu T, Liu Y, Huang P, Liu Z, Li K, Zhao B.

Mol Neurobiol. 2017 Apr;54(3):1939-1952. doi: 10.1007/s12035-016-9783-8. Epub 2016 Feb 22.

PMID:
26899576
19.

1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.

Guo YX, He LY, Zhang M, Wang F, Liu F, Peng WX.

Neuroscience. 2016 May 13;322:28-38. doi: 10.1016/j.neuroscience.2016.01.041. Epub 2016 Jan 25.

PMID:
26820600
20.

RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.

Wang P, Huang R, Lu S, Xia W, Cai R, Sun H, Wang S.

PLoS One. 2016 Jan 8;11(1):e0145521. doi: 10.1371/journal.pone.0145521. eCollection 2016.

Supplemental Content

Loading ...
Support Center